Patrick S. Bryant

• Represented a leading health care company in its acquisition of a publicly traded medical device company.

• Represented various companies in the health care industry in strategic investments, reorganizations, affiliations, joint ventures and other transactions.

• Represented special committee of privately held manufacturer in evaluating a shareholder distribution transaction.

• Represented a late-stage, privately held technology company in obtaining financing for, disclosing and executing a tender offer to existing equity holders.

• Represented an equity sponsor and selling stockholder in a technology company's initial public offering and secondary offerings.

• Represented a NYSE-listed issuer in disclosing and obtaining supermajority shareholder approval of curative changes to legacy charter documents and obtaining remedial approvals under state ratification statute.

• Represented the special board committee of a publicly traded service company in negotiating and completing a going private transaction.

• Represented the audit committee of a publicly traded financial services company in conducting an internal investigation of financial and accounting matters.

• Represented issuers in various industries and selling shareholders in IPO and secondary offering registrations.

• Represented a public software company in its acquisition by an international information solutions provider.

• Represented a manufacturer in its issuance of high-yield notes in a Rule 144A placement and subsequent registered exchange offer.

• Represented private equity firms and strategic buyers in investments in publicly traded companies.

• Represented publicly traded companies, their boards of directors and committees in compliance and disclosure matters under SEC regulations, exchange rules and related requirements.

• Represented issuers of securities in private placements in transaction structuring, exemption compliance and related matters.

Honors & Recognitions

News

Publications